Cognitive Function: Is There More to Anticoagulation in Atrial Fibrillation Than Stroke?

J Am Heart Assoc. 2015 Aug 3;4(8):e001573. doi: 10.1161/JAHA.114.001573.

Authors

Lin Cao¹, Sean D Pokorney², Kathleen Hayden³, Kathleen Welsh-Bohmer³, L Kristin Newby²

Affiliations

¹ North Carolina School of Science and Mathematics, Durham, NC (L.C.).
² Duke Clinical Research Institute, Duke University Medical Center, Durham, NC (S.D.P., K.N.) Duke University School of Medicine, Durham, NC (S.D.P., K.H., K.W.B., K.N.).
³ Duke University School of Medicine, Durham, NC (S.D.P., K.H., K.W.B., K.N.).

No abstract available

Keywords: anticoagulation; atrial fibrillation; cognitive impairment; silent brain infarction; stroke.

Publication types

Review

MeSH terms

Administration, Oral
Age Factors
Aged
Aged, 80 and over
Anticoagulants / administration & dosage
Anticoagulants / therapeutic use*
Atrial Fibrillation / diagnosis
Atrial Fibrillation / drug therapy*
Atrial Fibrillation / epidemiology
Atrial Fibrillation / psychology
Cognition / drug effects*
Cognitive Dysfunction / diagnosis
Cognitive Dysfunction / drug therapy*
Cognitive Dysfunction / epidemiology
Cognitive Dysfunction / psychology
Humans
Middle Aged
Risk Factors
Stroke / diagnosis
Stroke / epidemiology
Stroke / prevention & control*
Stroke / psychology
Treatment Outcome

Substances

Anticoagulants